U.S. Genome Editing Market (2024 - 2030) Size, Share & Trends Analysis Report By Technology (CRISPR, ZFN), By Delivery Method (Ex-vivo, In-vivo), By Mode (Contract, In-house), By Application, By End-use, And Segment Forecasts

Market Segmentation

U.S. Genome Editing Technology Outlook (Revenue, USD Million, 2018 - 2030)
- Meganucleases
- (CRISPR)/Cas9
- TALENs/MegaTALs
- ZFN
- Others
U.S. Genome Editing Delivery Method Outlook (Revenue, USD Million, 2018 - 2030)
- Ex-vivo
- In-vivo
U.S. Genome Editing Mode Outlook (Revenue, USD Million, 2018 - 2030)
- Contract
- In-house
U.S. Genome Editing Application Outlook (Revenue, USD Million, 2018 - 2030)
- Genetic Engineering
- Cell Line Engineering
- Animal Genetic Engineering
- Plant Genetic Engineering
- Others
- Clinical Applications
- Diagnostics
- Therapy Development
U.S. Genome Editing End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Biotechnology & Pharmaceutical Companies
- Academic & Government Research Institutes
- Contract Research Organizations

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments